Tobias M, Templeton R, Collings S
Public Health Intelligence, New Zealand Ministry of Health, New Zealand.
Tob Control. 2008 Oct;17(5):347-50. doi: 10.1136/tc.2008.026005. Epub 2008 Jul 31.
To quantify the share of tobacco consumed by people with 12-month mental disorders in New Zealand.
Estimates of current smoking prevalence and the 12-month prevalence of three groups of mental disorders--anxiety, mood and substance use disorders--were derived from the New Zealand Mental Health Survey, a nationally representative survey of almost 13,000 adults (16+ years) fielded in 2003-4. Estimates of the smoking intensity ratio (comparing smokers with mental disorders to those without mental disorders) were derived from the 2006-7 New Zealand Health Survey.
Approximately 33% of all cigarettes are consumed by people with 12-month mental disorders (males 27%, females 39%), using an estimated smoking intensity ratio of 1.21. Among this group, anxiety disorders account for almost one-half of consumption, mood disorders for over one-quarter and substance use disorders for about one-fifth.
This study quantifies for the first time the contribution of mental disorders to tobacco consumption in New Zealand. In particular, it identifies anxiety disorders as an important risk factor for tobacco use. People with mental disorders are an important target group for tobacco control. Enhanced collaboration and sharing of expertise between smoking cessation service providers and community mental health services are urgently needed.
量化新西兰患有12个月精神障碍的人群所消费烟草的份额。
当前吸烟流行率以及三组精神障碍(焦虑症、情绪障碍和物质使用障碍)的12个月患病率估计值,来自于2003 - 2004年开展的新西兰心理健康调查,这是一项对近13000名成年人(16岁及以上)具有全国代表性的调查。吸烟强度比(将患有精神障碍的吸烟者与未患精神障碍的吸烟者进行比较)的估计值来自于2006 - 2007年新西兰健康调查。
患有12个月精神障碍的人群消费了所有香烟的约33%(男性为27%,女性为39%),估计吸烟强度比为1.21。在这一群体中,焦虑症占消费的近一半,情绪障碍占四分之一以上,物质使用障碍占约五分之一。
本研究首次量化了精神障碍对新西兰烟草消费的影响。特别是,它将焦虑症确定为烟草使用的一个重要风险因素。患有精神障碍的人群是烟草控制的一个重要目标群体。迫切需要戒烟服务提供者与社区心理健康服务机构之间加强合作并共享专业知识。